Shabir Madhi to C-Reactive Protein
This is a "connection" page, showing publications Shabir Madhi has written about C-Reactive Protein.
Connection Strength
1,032
-
Lessons learned from clinical trials evaluating pneumococcal conjugate vaccine efficacy against pneumonia and invasive disease. Vaccine. 2008 Jun 16; 26 Suppl 2:B9-B15.
Score: 0,296
-
Usefulness of C-reactive protein to define pneumococcal conjugate vaccine efficacy in the prevention of pneumonia. Pediatr Infect Dis J. 2006 Jan; 25(1):30-6.
Score: 0,249
-
Use of procalcitonin and C-reactive protein to evaluate vaccine efficacy against pneumonia. PLoS Med. 2005 Feb; 2(2):e38.
Score: 0,235
-
Association of C-Reactive Protein With Bacterial and Respiratory Syncytial Virus-Associated Pneumonia Among Children Aged <5 Years in the PERCH Study. Clin Infect Dis. 2017 Jun 15; 64(suppl_3):S378-S386.
Score: 0,138
-
The discriminative value of C-reactive protein levels in distinguishing between community-acquired bacteraemic and respiratory virus-associated lower respiratory tract infections in HIV-1-infected and -uninfected children. Ann Trop Paediatr. 2002 Sep; 22(3):271-9.
Score: 0,049
-
Cytokine profiles in children with acute intussusception in South Africa. Cytokine. 2021 10; 146:155639.
Score: 0,046
-
Novel approaches to the identification of Streptococcus pneumoniae as the cause of community-acquired pneumonia. Clin Infect Dis. 2008 Dec 01; 47 Suppl 3:S202-6.
Score: 0,019